An Alternative Dosing Schedule of Varenicline for Smoking Cessation

Completed · Phase 2 · Has a placebo group

Conditions studied: Smoking Cessation

In brief

The purpose of this study is to explore the use of an prolonged alternative dosing schedule using varenicline for smoking cessation leading to greater quit rates and higher rates of continuous abstinence.

Key facts

Study ID

NCT00835900

Run by

Roswell Park Cancer Institute

People needed

60

Starts

2009-03-01

Expected to finish

2015-07-01

Last updated by the study team

2017-05-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• currently smoking at least 15 cigarettes daily
• in good health
• able to read and speak English fluently
• have a home telephone and plan to reside in Western New York for 6 months
• willing to make quit attempt
• signed informed consent
• who planned quit attempt.

You may not qualify if…

• serious medical condition
• depression or mental health condition requiring treatment in the past year
• history of panic disorder, psychosis, bipolar disorder
• alcohol or drug abuse in the past year
• use of tobacco products other than cigarettes
• current use of other cessation pharmacotherapies
• pregnancy/planned pregnancy.

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.